Analysed APTOSE BIOSCIENCES INC (APTOF:OTCMKTS) News Sources
Aptose Biosciences Announces Results of Special Shareholders Meeting; Announces Receipt of Final Court Approval of Plan of Arrangement; Reports Year End 2025 Results and Corporate Highlights
31-03-2026
yahoo.com
Leading Independent Proxy Advisory Firm Glass Lewis Endorses Aptose Plan of Arrangement
23-03-2026
yahoo.com
Leading Independent Proxy Advisory Firm ISS Recommends Aptose Biosciences Shareholders Vote “FOR” Proposed Plan of Arrangement with Hanmi Pharmaceutical
19-03-2026
yahoo.com
Aptose Biosciences Announces Amendment to Arrangement Agreement and Details of Postponed Special Meeting of Shareholders
24-02-2026
yahoo.com
Aptose Biosciences Announces Rescheduling of Special Meeting of Shareholders to Approve the Acquisition by Hanmi Pending Final Clearance from SEC
19-12-2025
yahoo.com
Aptose’s Tuspetinib Triple Drug Therapy Featured at the 2025 ASH Annual Meeting; High Rate of Frontline Clinical Responses Continues Across AML Populations
06-12-2025
yahoo.com
Aptose Biosciences Announces Arrangement Agreement for Acquisition by Hanmi Pharmaceutical
19-11-2025
yahoo.com
What is the current price of APTOSE BIOSCIENCES INC (APTOF:OTCMKTS)?
The current price of APTOSE BIOSCIENCES INC (APTOF:OTCMKTS) is $1.73.
APTOSE BIOSCIENCES INC (APTOF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of APTOSE BIOSCIENCES INC (APTOF:OTCMKTS) since the previous trading day is $0.
APTOSE BIOSCIENCES INC (APTOF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of APTOSE BIOSCIENCES INC (APTOF:OTCMKTS) since the previous trading day is 0%.
What is the most recent average sentiment score for APTOSE BIOSCIENCES INC (APTOF:OTCMKTS)?
The most recent average sentiment score for APTOSE BIOSCIENCES INC (APTOF:OTCMKTS) is 73 out of 100.
What is the most recent average sentiment for APTOSE BIOSCIENCES INC (APTOF:OTCMKTS)?
The most recent sentiment for APTOSE BIOSCIENCES INC (APTOF:OTCMKTS) is .
SEC-8K** Filing Available For APTOSE BIOSCIENCES INC (APTOF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.